HedgeChatter

  • Home /
  • Tag Archives

EDAP

EDAP Announces First Focal One(R) HIFU Treatments Performed in Germany

[GlobeNewswire] – LYON, France — EDAP TMS SA , the global leader in therapeutic ultrasound, reported the first Focal One HIFU treatments performed in Germany. moreView todays social media effects on EDAPView the latest stocks trending across Twitter. Click to view dashboardSee who EDAP is hiring next, click here to view […]

May 6, 2014 Bystocknews , Comments Off on EDAP Announces First Focal One(R) HIFU Treatments Performed in Germany read more

EDAP Delivers Focal One(R) Device for Focal Treatment of Prostate Cancer to Hospital in Poland

[GlobeNewswire] – LYON, France — EDAP TMS SA , the global leader in therapeutic ultrasound, announced today the installation of its Focal One device at the ESKULAP Private Hospital in Bydgoszcz, Poland. Focal One is the … moreView todays social media effects on EDAPView the latest stocks trending across Twitter. Click to view dashboardSee who EDAP is hiring next, click […]

February 11, 2014 Bystocknews , Comments Off on EDAP Delivers Focal One(R) Device for Focal Treatment of Prostate Cancer to Hospital in Poland read more

EDAP TMS SA Financials

moreView todays social media effects on EDAPView the latest stocks trending across Twitter. Click to view dashboardSee who EDAP is hiring next, click here to view […]

April 6, 2013 Bystocknews , Comments Off on EDAP TMS SA Financials read more

EDAP Introduces Focal.One(R): A New Robotic HIFU Device for Focal Therapy of Prostate Cancer

[at noodls] – LYON, France, March 14, 2013 (GLOBE NEWSWIRE) — EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the launch of Focal.One®, its new and innovative robotic HIFU device … moreView todays social media effects on EDAPView the latest stocks trending across Twitter. Click to view dashboardSee who EDAP is hiring next, click here to […]

March 14, 2013 Bystocknews , Comments Off on EDAP Introduces Focal.One(R): A New Robotic HIFU Device for Focal Therapy of Prostate Cancer read more

EDAP Receives U.S. FDA Administrative Acceptance Review Notification for Ablatherm(R)-HIFU Pre-Market Approval Application

[at noodls] – LYON, France, March 7, 2013 (GLOBE NEWSWIRE) — EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the U.S. Food and Drug Administration (FDA) has provided a positive … moreView todays social media effects on EDAPView the latest stocks trending across Twitter. Click to view dashboardSee who EDAP is hiring next, click here […]

March 7, 2013 Bystocknews , Comments Off on EDAP Receives U.S. FDA Administrative Acceptance Review Notification for Ablatherm(R)-HIFU Pre-Market Approval Application read more